Acute psychological stress accelerates reverse cholesterol transport via corticosterone-dependent inhibition of intestinal cholesterol absorption

Circulation Research

Volumn 111, Issue 11, 2012, Pages 1459-1469

  Silvennoinen, Reija ^a   Escola Gil, Joan Carles ^b   Julve, Josep ^b   Rotllan, Noemi ^b   Llaverias, Gemma ^b   Metso, Jari ^c   Valledor, Annabel F ^d   He, Jianming ^e   Yu, Liqing ^e   Jauhiainen, Matti ^c   Blanco Vaca, Francisco ^b   Kovanen, Petri T ^a   Lee Rueckert, Miriam ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF BARCELONA   (Spain)

^e UNIVERSITY OF MARYLAND   (United States)

Author keywords

atherosclerosis; corticosterone; liver X receptor a; peroxisome proliferator activated receptor ; reverse cholesterol transport; stress

Indexed keywords

CHOLESTEROL; CORTICOSTERONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTESTINE ABSORPTION; LIPID ABSORPTION; MACROPHAGE; MENTAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE CHOLESTEROL TRANSPORT;

ACUTE DISEASE; ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CELL LINE; CHOLESTEROL; CORTICOSTERONE; FEMALE; GENE EXPRESSION; HUMANS; INTESTINAL ABSORPTION; INTESTINE, SMALL; LIPIDS; LIVER; MACROPHAGES; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; ORPHAN NUCLEAR RECEPTORS; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS, PSYCHOLOGICAL;

EID: 84870032418     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.277962     Document Type: Article

References (67)

1. Koolhaas JM, Bartolomucci A, Buwalda B, et al. Stress revisited: a critical evaluation of the stress concept. Neurosci Biobehav Rev. 2011;35:1291-1301.
2. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192-2217.
3. Steptoe A, Brydon L. Emotional triggering of cardiac events. Neurosci Biobehav Rev. 2009;33:63-70.
4. Barnett PA, Spence JD, Manuck SB, Jennings Jr. Psychological stress and the progression of carotid artery disease. J Hypertens. 1997;15:49-55.
5. Wolff B, Grabe HJ, Vlzke H, Ldemann J, Kessler C, Dahm JB, Freyberger HJ, John U, Felix SB. Relation between psychological strain and carotid atherosclerosis in a general population. Heart. 2005;91:460-464.
6. Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann N Y Acad Sci. 1995;771:1-18.
7. Chrousos GP, Kino T. Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress. 2007;10:213-219.
8. Wang Y, Lu Y, Yu D, Wang Y, Chen F, Yang H, Zheng SJ. Enhanced resistance of restraint-stressed mice to sepsis. J Immunol. 2008;181:3441-3448.
9. De Bie JJ, Hessel EM, Van Ark I, Van Esch B, Hofman G, Nijkamp FP, Van Oosterhout AJ. Effect of dexamethasone and endogenous corticos-terone on airway hyperresponsiveness and eosinophilia in the mouse. Br J Pharmacol. 1996;119:1484-1490.
10. Peebles RS Jr, Togias A, Bickel CA, Diemer FB, Hubbard WC, Schleimer RP. Endogenous glucocorticoids and antigen-induced acute and late phase pulmonary responses. Clin Exp Allergy. 2000;30:1257-1265.
11. Buynitsky T, Mostofsky DI. Restraint stress in biobehavioral research: Recent developments. Neurosci Biobehav Rev. 2009;33:1089-1098.
12. Kumari M, Grahame-Clarke C, Shanks N, Marmot M, Lightman S, Vallance P. Chronic stress accelerates atherosclerosis in the apolipopro-tein E defcient mouse. Stress. 2003;6:297-299.
13. Bernberg E, Andersson IJ, Tidstrand S, Johansson ME, Bergstrm G. Repeated exposure to stressors do not accelerate atherosclerosis in ApoE-/-mice. Atherosclerosis. 2009;204:90-95.
14. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.
15. Cuchel M, Rader DJ. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation. 2006;113:2548-2555.
16. Rader DJ, Alexander ET, Weibel GL, Billheimer J, Rothblat GH. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res. 2009;50(Suppl):S189-S194.
17. Escola-Gil JC, Rotllan N, Julve J, Blanco-Vaca F. In vivo macrophage-specifc RCT and antioxidant and antiinfammatory HDL activity measurements: New tools for predicting HDL atheroprotection. Atherosclerosis. 2009;206:321-327.
18. Lee-Rueckert M, Silvennoinen R, Rotllan N, Judstrom I, Blanco-Vaca F, Metso J, Jauhiainen M, Kovanen PT, Escola-Gil JC. Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse. Arterioscler Thromb Vasc Biol. 2011;31:520-527.
19. Judstrom I, Jukkola H, Metso J, Jauhiainen M, Kovanen PT, Lee-Rueckert M. Mast cell-dependent proteolytic modifcation of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol effux from macrophage foam cells ex vivo. Atherosclerosis. 2010;208:148-154.
20. Julve J, Escol-Gil JC, Ribas V, Gonzlez-Sastre F, Ordez-Llanos J, Snchez-Quesada JL, Blanco-Vaca F. Mechanisms of HDL defciency in mice overexpressing human apoA-II. J Lipid Res. 2002;43:1734-1742.
21. Grundy SM, Ahrens EH Jr, Salen G. Dietary beta-sitosterol as an internal standard to correct for cholesterol losses in sterol balance studies. J Lipid Res. 1968;9:374-387.
22. Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest. 1987;80:184-190.
23. Andrews MH, Wood SA, Windle RJ, Lightman SL, Ingram CD. Acute glucocorticoid administration rapidly suppresses basal and stress-induced hypothalamo-pituitary-adrenal axis activity. Endocrinology. 2012;153:200-211.
24. Toh SA, Millar JS, Billheimer J, Fuki I, Naik SU, Macphee C, Walker M, Rader DJ. PPARγ activation redirects macrophage cholesterol from fecal excretion to adipose tissue uptake in mice via SR-BI. Biochem Pharmacol. 2011;81:934-941.
25. Nakade Y, Fukuda H, Iwa M, Tsukamoto K, Yanagi H, Yamamura T, Mantyh C, Pappas TN, Takahashi T. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1037-G1044.
26. Davis HR Jr, Altmann SW. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter. Biochim Biophys Acta. 2009;1791:679-683.
27. Sehayek E, Hazen SL. Cholesterol absorption from the intestine is a major determinant of reverse cholesterol transport from peripheral tissue macrophages. Arterioscler Thromb Vasc Biol. 2008;28:1296-1297.
28. Briand F, Naik SU, Fuki I, Millar JS, Macphee C, Walker M, Billheimer J, Rothblat G, Rader DJ. Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol. Clin Transl Sci. 2009;2:127-133.
29. van der Veen JN, Kruit JK, Havinga R, Baller JF, Chimini G, Lestavel S, Staels B, Groot PH, Groen AK, Kuipers F. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res. 2005;46:526-534.
30. Wang X, Collins HL, Ranalletta M, Fuki IV, Billheimer JT, Rothblat GH, Tall AR, Rader DJ. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest. 2007;117:2216-2224.
31. Levy E, Spahis S, Sinnett D, Peretti N, Maupas-Schwalm F, Delvin E, Lambert M, Lavoie MA. Intestinal cholesterol transport proteins: an update and beyond. Curr Opin Lipidol. 2007;18:310-318.
32. Valasek MA, Clarke SL, Repa JJ. Fenofbrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse. J Lipid Res. 2007;48:2725-2735.
33. Tach Y, Bonaz B. Corticotropin-releasing factor receptors and stress-related alterations of gut motor function. J Clin Invest. 2007;117:3340.
34. Plump AS, Erickson SK, Weng W, Partin JS, Breslow JL, Williams DL. Apolipoprotein A-I is required for cholesteryl ester accumulation in ste-roidogenic cells and for normal adrenal steroid production. J Clin Invest. 1996;97:2660-2671.
35. Knight BL, Patel DD, Humphreys SM, Wiggins D, Gibbons GF. Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice. J Lipid Res. 2003;44:2049-2058.
36. van der Velde AE, Brufau G, Groen AK. Transintestinal cholesterol ef-fux. Curr Opin Lipidol. 2010;21:167-171.
37. Vrins CL, van der Velde AE, van den Oever K, Levels JH, Huet S, Oude Elferink RP, Kuipers F, Groen AK. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol ef-fux. J Lipid Res. 2009;50:2046-2054.
38. Duval C, Touche V, Tailleux A, Fruchart JC, Fievet C, Clavey V, Staels B, Lestavel S. Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem Biophys Res Commun. 2006;340:1259-1263.
39. Lo Sasso G, Murzilli S, Salvatore L, DErrico I, Petruzzelli M, Conca P, Jiang ZY, Calabresi L, Parini P, Moschetta A. Intestinal specifc LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab. 2010;12:187-193.
40. Colin S, Bourguignon E, Boullay AB, Tousaint JJ, Huet S, Caira F, Staels B, Lestavel S, Lobaccaro JM, Delerive P. Intestine-specifc regulation of PPARalpha gene transcription by liver X receptors. Endocrinology. 2008;149:5128-5135.
41. Perez-Tilve D, Hofmann SM, Basford J, et al. Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat Neurosci. 2010;13:877-882.
42. Liu J, Garza JC, Li W, Lu XY. Melanocortin-4 receptor in the medial amygdala regulates emotional stress-induced anxiety-like behaviour, anorexia and corticosterone secretion. Int J Neuropsychopharmacol. December 16, 2011. doi:10.1017/S146114571100174X: http://journals. cambridge.org/action/ displayAbstract?fromPage=online&aid=8458320. Accessed September 20, 2012.
43. Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, Rader DJ. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest. 2005;115:2870-2874.
44. Rodrguez-Sureda V, Lpez-Tejero MD, Llobera M, Peinado-Onsurbe J. Social stress profoundly affects lipid metabolism: over-expression of SR-BI in liver and changes in lipids and lipases in plasma and tissues of stressed mice. Atherosclerosis. 2007;195:57-65.
45. Ogata M, Tsujita M, Hossain MA, Akita N, Gonzalez FJ, Staels B, Suzuki S, Fukutomi T, Kimura G, Yokoyama S. On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis. 2009;205:413-419.
46. Nakaya K, Tohyama J, Naik SU, Tanigawa H, MacPhee C, Billheimer JT, Rader DJ. Peroxisome proliferator-activated receptor-a activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathway. Arterioscler Thromb Vasc Biol. 2011;31:1276-1282.
47. Ayaori M, Sawada S, Yonemura A, Iwamoto N, Ogura M, Tanaka N, Nakaya K, Kusuhara M, Nakamura H, Ohsuzu F. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apoli-poprotein-mediated cholesterol effux from macrophages. Arterioscler Thromb Vasc Biol. 2006;26:163-168.
48. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, Wahli W. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J Biol Chem. 1994;269:24527-24530.
49. Lemberger T, Saladin R, Vzquez M, Assimacopoulos F, Staels B, Desvergne B, Wahli W, Auwerx J. Expression of the peroxisome prolif-erator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem. 1996;271:1764-1769.
50. Cuzzocrea S, Bruscoli S, Mazzon E, Crisafulli C, Donato V, Di Paola R, Velardi E, Esposito E, Nocentini G, Riccardi C. Peroxisome proliferator- activated receptor-alpha contributes to the anti-infammatory activity of glucocorticoids. Mol Pharmacol. 2008;73:323-337.
51. Riccardi L, Mazzon E, Bruscoli S, Esposito E, Crisafulli C, Di Paola R, Caminiti R, Riccardi C, Cuzzocrea S. Peroxisome proliferator-activated receptor-alpha modulates the anti-infammatory effect of glucocorticoids in a model of infammatory bowel disease in mice. Shock. 2009;31:308-316.
52. Calpe-Berdiel L, Rotllan N, Fivet C, Roig R, Blanco-Vaca F, Escola-Gil JC. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. J Lipid Res. 2008;49:1904-1911.
53. McNeish J, Aiello RJ, Guyot D, Turi T, Gabel C, Aldinger C, Hoppe KL, Roach ML, Royer LJ, de Wet J, Broccardo C, Chimini G, Francone OL. High density lipoprotein defciency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA. 2000;97:4245-4250.
54. Drobnik W, Lindenthal B, Lieser B, Ritter M, Christiansen Weber T, Liebisch G, Giesa U, Igel M, Borsukova H, Bchler C, Fung-Leung WP, Von Bergmann K, Schmitz G. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. Gastroenterology. 2001;120:1203-1211.
55. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ. Regulation of absorption and ABC1-mediated effux of cholesterol by RXR heterodimers. Science. 2000;289:1524-1529.
56. Yasuda T, Grillot D, Billheimer JT, Briand F, Delerive P, Huet S, Rader DJ. Tissue-specifc liver X receptor activation promotes macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol. 2010;30:781-786.
57. Wang T, Shah YM, Matsubara T, Zhen Y, Tanabe T, Nagano T, Fotso S, Krausz KW, Zabriskie TM, Idle JR, Gonzalez FJ. Control of steroid 21-oic acid synthesis by peroxisome proliferator-activated receptor alpha and role of the hypothalamic-pituitary-adrenal axis. J Biol Chem. 2010;285:7670-7685.
58. Cummins CL, Volle DH, Zhang Y, McDonald JG, Sion B, Lefranois-Martinez AM, Caira F, Veyssire G, Mangelsdorf DJ, Lobaccaro JM. Liver X receptors regulate adrenal cholesterol balance. J Clin Invest. 2006;116:1902-1912.
59. Castagliuolo I, Lamont JT, Qiu B, Fleming SM, Bhaskar KR, Nikulasson ST, Kornetsky C, Pothoulakis C. Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am J Physiol. 1996;271:G884-G892.
60. Tsukada F, Sugawara M, Kohno H, Ohkubo Y. Evaluation of the effects of restraint and footshock stress on small intestinal motility by an improved method using a radionuclide, 51Cr, in the rat. Biol Pharm Bull. 2001;24:488-490.
61. Masere C, Nakade Y, Zheng J, Babygirija R, Ludwig K, Takahashi T. Chronic restraint stress has no more stimulatory effects on colonic motil-ity in rats. Neurosci Lett. 2009;453:147-150.
62. Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, Davies JP, Nilsson LM, Yu L. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest. 2007;117:1968-1978.
63. Kaplan JR, Manuck SB, Clarkson TB, Lusso FM, Taub DM, Miller EW. Social stress and atherosclerosis in normocholesterolemic monkeys. Science. 1983;220:733-735.
64. McCabe PM, Gonzales JA, Zaias J, Szeto A, Kumar M, Herron AJ, Schneiderman N. Social environment infuences the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. Circulation. 2002;105:354-359.
65. Bernberg E, Ulleryd MA, Johansson ME, Bergstrm GM. Social disruption stress increases IL-6 levels and accelerates atherosclerosis in ApoE-/-mice. Atherosclerosis. 2012;221:359-365.
66. Lu XT, Liu YF, Zhao L, Li WJ, Yang RX, Yan FF, Zhao YX, Jiang F. Chronic psychological stress induces vascular infammation in rabbits. Stress. 2012. [Epub ahead of print]
67. Marcondes MC, Zhukov V, Bradlow H, Sanchez-Alavez M, Gonzalez AS, Curtiss LK, Conti B. Effects of chronic mental stress and athero-genic diet on the immune infammatory environment in mouse aorta. Brain Behav Immun. 2011;25:1649-1657.